Anthem (ANTM) Releases FY 2018 Earnings Guidance

Share on StockTwits

Anthem (NYSE:ANTM) issued an update on its FY 2018 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $15.60 for the period, compared to the Thomson Reuters consensus estimate of $15.50. The company issued revenue guidance of $91-92 billion, compared to the consensus revenue estimate of $91.43 billion.

NYSE:ANTM traded up $10.98 during mid-day trading on Wednesday, reaching $276.47. The stock had a trading volume of 133,094 shares, compared to its average volume of 1,237,592. The company has a market capitalization of $69.08 billion, a price-to-earnings ratio of 22.93, a PEG ratio of 1.44 and a beta of 0.92. Anthem has a one year low of $206.98 and a one year high of $283.06. The company has a debt-to-equity ratio of 0.61, a current ratio of 1.52 and a quick ratio of 1.52.

Anthem (NYSE:ANTM) last released its earnings results on Wednesday, October 31st. The company reported $3.81 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.70 by $0.11. The company had revenue of $22.98 billion during the quarter, compared to the consensus estimate of $22.85 billion. Anthem had a return on equity of 13.28% and a net margin of 4.79%. Anthem’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.65 EPS. As a group, sell-side analysts anticipate that Anthem will post 15.48 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, December 21st. Investors of record on Wednesday, December 5th will be given a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a yield of 1.09%. Anthem’s payout ratio is 24.92%.

ANTM has been the subject of a number of recent research reports. Cantor Fitzgerald restated a buy rating and issued a $275.00 target price on shares of Anthem in a research report on Thursday, October 25th. Jefferies Financial Group restated a buy rating and issued a $316.00 target price on shares of Anthem in a research report on Friday, October 12th. Morgan Stanley boosted their target price on Anthem from $269.00 to $273.00 and gave the stock an equal weight rating in a research report on Thursday, July 26th. Zacks Investment Research downgraded Anthem from a buy rating to a hold rating in a research report on Tuesday, July 3rd. Finally, Citigroup downgraded Anthem from a buy rating to a neutral rating and set a $162.00 price objective for the company. in a research report on Monday, September 10th. Three equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. The company has an average rating of Buy and an average price target of $274.21.

In other news, CAO Ronald W. Penczek sold 763 shares of the business’s stock in a transaction that occurred on Tuesday, September 4th. The stock was sold at an average price of $265.56, for a total transaction of $202,622.28. Following the transaction, the chief accounting officer now directly owns 1,334 shares of the company’s stock, valued at $354,257.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Julie A. Hill sold 248 shares of the business’s stock in a transaction that occurred on Thursday, August 16th. The shares were sold at an average price of $267.01, for a total value of $66,218.48. Following the transaction, the director now directly owns 34,827 shares in the company, valued at $9,299,157.27. The disclosure for this sale can be found here. Insiders sold 15,447 shares of company stock valued at $4,143,846 in the last quarter. Corporate insiders own 0.31% of the company’s stock.

Anthem Company Profile

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.

Further Reading: Short Selling – Explanation For Shorting Stocks

Earnings History and Estimates for Anthem (NYSE:ANTM)

Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with's FREE daily email newsletter.

Leave a Reply